Market News

Pdt Partners Has Cut Its Ball (BLL) Position; Ibio (IBIO)’s Sentiment Is 1.33

iBio, Inc. (NYSEAMERICAN:IBIO) Logo

Pdt Partners Llc decreased Ball Corp (BLL) stake by 16.33% reported in 2017Q4 SEC filing. Pdt Partners Llc sold 87,493 shares as Ball Corp (BLL)’s stock rose 3.21%. The Pdt Partners Llc holds 448,439 shares with $16.97M value, down from 535,932 last quarter. Ball Corp now has $14.26 billion valuation. The stock decreased 0.61% or $0.25 during the last trading session, reaching $40.67. About 2.01M shares traded. Ball Corporation (NYSE:BLL) has risen 6.31% since April 21, 2017 and is uptrending. It has underperformed by 5.24% the S&P500.

Ibio Inc (IBIO) investors sentiment increased to 1.33 in 2017 Q4. It’s up 0.08, from 1.25 in 2017Q3. The ratio has improved, as 4 investment managers started new and increased positions, while 3 trimmed and sold positions in Ibio Inc. The investment managers in our database now have: 2.71 million shares, down from 2.98 million shares in 2017Q3. Also, the number of investment managers holding Ibio Inc in top ten positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 1 Increased: 3 New Position: 1.

The stock decreased 4.66% or $0.0079 during the last trading session, reaching $0.1618. About 592,817 shares traded. iBio, Inc. (IBIO) has declined 47.72% since April 21, 2017 and is downtrending. It has underperformed by 59.27% the S&P500.

iBio, Inc., a biotechnology company, focuses on developing and commercializing pharmaceutical product applications using its platform in the United States and internationally. The company has market cap of $18.76 million. The Company’s lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It currently has negative earnings. It is also developing vaccine candidates for third parties.

Bank Of America Corp De holds 0% of its portfolio in iBio, Inc. for 4,000 shares. Bank Of New York Mellon Corp owns 73,865 shares or 0% of their US portfolio. Moreover, Blackrock Inc. has 0% invested in the company for 175,632 shares. The Ohio-based Fifth Third Bancorp has invested 0% in the stock. Geode Capital Management Llc, a Massachusetts-based fund reported 342,667 shares.

Since January 5, 2018, it had 1 insider purchase, and 10 sales for $1.64 million activity. STRAIN ROBERT D sold 2,500 shares worth $98,900. Shares for $272,890 were sold by Pauley Lisa Ann on Thursday, February 15. Shares for $86,202 were sold by MORRISON SCOTT C. Peterson James N sold $170,532 worth of stock. HOOVER R DAVID sold 2,200 shares worth $89,562. $360,900 worth of stock was bought by Fisher Daniel William on Tuesday, February 27. $261,823 worth of stock was sold by HAYES JOHN A on Friday, January 5.

Pdt Partners Llc increased M D C Hldgs Inc (NYSE:MDC) stake by 15,261 shares to 202,111 valued at $6.44M in 2017Q4. It also upped Cigna Corporation (NYSE:CI) stake by 10,702 shares and now owns 147,300 shares. Mylan N V (NASDAQ:MYL) was raised too.

Analysts await Ball Corporation (NYSE:BLL) to report earnings on May, 3 before the open. They expect $0.42 earnings per share, up 10.53% or $0.04 from last year’s $0.38 per share. BLL’s profit will be $147.23 million for 24.21 P/E if the $0.42 EPS becomes a reality. After $0.60 actual earnings per share reported by Ball Corporation for the previous quarter, Wall Street now forecasts -30.00% negative EPS growth.

Investors sentiment decreased to 1.31 in 2017 Q4. Its down 0.03, from 1.34 in 2017Q3. It is negative, as 33 investors sold BLL shares while 129 reduced holdings. 75 funds opened positions while 138 raised stakes. 292.68 million shares or 3.20% less from 302.34 million shares in 2017Q3 were reported. The Korea-based National Pension has invested 0.07% in Ball Corporation (NYSE:BLL). Alphaone Investment Svcs Ltd Co holds 2,509 shares. New York State Teachers Retirement Sys owns 0.04% invested in Ball Corporation (NYSE:BLL) for 473,547 shares. Cap Fund Mgmt Sa owns 93,550 shares for 0.02% of their portfolio. Brown Advisory Secs Ltd Liability Corp holds 6,970 shares or 0.05% of its portfolio. Secor Cap Advisors Ltd Partnership stated it has 105,527 shares or 0.16% of all its holdings. Omega Inc invested in 0.71% or 501,955 shares. Lincoln Corporation has invested 0.01% of its portfolio in Ball Corporation (NYSE:BLL). Shelton Cap Mgmt reported 22,168 shares. Cibc World Mkts holds 0.02% or 70,730 shares. Ww Asset stated it has 0.04% of its portfolio in Ball Corporation (NYSE:BLL). Macquarie Group Inc holds 0% or 5,900 shares in its portfolio. Ngam Advsrs Limited Partnership holds 16,426 shares. Keybank Natl Association Oh owns 50,034 shares for 0.01% of their portfolio. State Board Of Administration Of Florida Retirement Sys holds 461,836 shares or 0.05% of its portfolio.

Among 14 analysts covering Ball Corporation (NYSE:BLL), 10 have Buy rating, 0 Sell and 4 Hold. Therefore 71% are positive. Ball Corporation had 38 analyst reports since October 15, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, December 9 by Jefferies. The stock of Ball Corporation (NYSE:BLL) has “Neutral” rating given on Friday, July 29 by Citigroup. Vertical Research upgraded Ball Corporation (NYSE:BLL) on Friday, February 3 to “Buy” rating. The stock has “Buy” rating by Jefferies on Friday, June 23. On Thursday, April 13 the stock rating was maintained by BMO Capital Markets with “Hold”. Citigroup upgraded Ball Corporation (NYSE:BLL) on Wednesday, January 17 to “Buy” rating. The rating was maintained by Robert W. Baird on Friday, November 3 with “Neutral”. The rating was maintained by Jefferies on Thursday, August 3 with “Buy”. Citigroup maintained the stock with “Neutral” rating in Friday, August 5 report. UBS initiated Ball Corporation (NYSE:BLL) rating on Monday, October 23. UBS has “Buy” rating and $50.0 target.

iBio, Inc. (NYSEAMERICAN:IBIO) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *